Studies of how intravenously injected nanoparticles (NPs) enter tumours and are taken up by tumour cells have been discussed for more than three decades. Despite this, we still have much to learn about interactions between NPs and how they can be transported across the endothelial cell layer. More studies are required before firm conclusions can be drawn regarding the contribution of passive or energy dependent mechanisms for transport of NPs over the endothelial cells allowing the NPs to reach solid tumours
Specific delivery of therapeutic and diagnostic agents to the disease tissue is an essential step fo...
Since the past decades, nanoparticles have been extensively used as drug carriers and several nanome...
Nanoparticles (NPs) are being used or explored for the development of biomedical applications in dia...
The successful delivery of nanoparticles to solid tumors depends on their ability to pass through bl...
Nanoparticles are not as well understood as they could be--they do pose a potential risk to human he...
Targeting of nanoparticles to tumours can potentially improve the specificity of imaging and treatme...
The selective entry of nanoparticles into target tissues is the key factor which determines their ti...
Cancer targeting nanoparticles face a variety of biological environments between the site of injecti...
The selective entry of nanoparticles into target tissues is the key factor which determines their ti...
The selective entry of nanoparticles into target tissues is the key factor which determines their ti...
In order to improve the current success of nanomedicine, a better understanding of how nano-sized ma...
The selective entry of nanoparticles into target tissues is the key factor which determines their ti...
The administration of nanoparticles (NPs) first faces the challenges of evading renal filtration and...
Nanoparticles (NP) are attractive options for the therapeutic delivery of active pharmaceutical drug...
Nanoparticles (NPs) have gained a lot of interest in recent years due to their huge potential for ap...
Specific delivery of therapeutic and diagnostic agents to the disease tissue is an essential step fo...
Since the past decades, nanoparticles have been extensively used as drug carriers and several nanome...
Nanoparticles (NPs) are being used or explored for the development of biomedical applications in dia...
The successful delivery of nanoparticles to solid tumors depends on their ability to pass through bl...
Nanoparticles are not as well understood as they could be--they do pose a potential risk to human he...
Targeting of nanoparticles to tumours can potentially improve the specificity of imaging and treatme...
The selective entry of nanoparticles into target tissues is the key factor which determines their ti...
Cancer targeting nanoparticles face a variety of biological environments between the site of injecti...
The selective entry of nanoparticles into target tissues is the key factor which determines their ti...
The selective entry of nanoparticles into target tissues is the key factor which determines their ti...
In order to improve the current success of nanomedicine, a better understanding of how nano-sized ma...
The selective entry of nanoparticles into target tissues is the key factor which determines their ti...
The administration of nanoparticles (NPs) first faces the challenges of evading renal filtration and...
Nanoparticles (NP) are attractive options for the therapeutic delivery of active pharmaceutical drug...
Nanoparticles (NPs) have gained a lot of interest in recent years due to their huge potential for ap...
Specific delivery of therapeutic and diagnostic agents to the disease tissue is an essential step fo...
Since the past decades, nanoparticles have been extensively used as drug carriers and several nanome...
Nanoparticles (NPs) are being used or explored for the development of biomedical applications in dia...